In recent years, there has been a tremendous development of biotechnological,
pharmacological, and medical techniques which can be implemented in the functional …

Exosomes are membrane-enclosed nanovesicles (30–150 nm) that shuttle active cargoes
between different cells. These tiny extracellular vesicles have been recently isolated from …

Compelling evidence exists that non-haematopoietic stem cells, including mesenchymal
(MSCs) and neural/progenitor stem cells (NPCs), exert a substantial beneficial and …

Due to their self-renewal capacity, multilineage differentiation potential, paracrine effects,
and immunosuppressive properties, mesenchymal stromal cells (MSCs) are an attractive …

The low regeneration potential of the central nervous system (CNS) represents a challenge
for the development of new therapeutic strategies. Mesenchymal stem cells (MSCs) have …

The use of human mesenchymal stem cells (hMSCs) has emerged as a possible therapeutic
strategy for CNS-related conditions. Research in the last decade strongly suggests that MSC …

Mesenchymal stem cells (MSCs) are promising tools for the treatment of diseases such as
infarcted myocardia and strokes because of their ability to promote endogenous …

The Human Mesenchymal Stem Cell (hMSC) secretome has pleiotropic effects
underpinning its therapeutic potential. hMSC serum-free conditioned media (SFCM) …

Mesenchymal stem cells (MSCs) are multipotent cells with a substantial potential in human
regenerative medicine due to their ability to migrate to sites of injury, capability to suppress …

Spinal cord injury (SCI) is a central nervous system‐(CNS‐) related disorder for which there
is yet no successful treatment. Within the past several years, cell‐based therapies have …